PeterPLaCameraMD
Pulmonology • Boston, MAAsthma & COPD, Critical Care Medicine, Interstitial Lung Diseases, Occupational & Environmental Lung Disease
Assistant Professor, Medicine, Tufts Medical Center
Dr. LaCamera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
736 Cambridge St.
St. Elizabeth's Pulmonary And Critical Care
Boston, MA 02135Phone+1 617-789-2545Fax+1 617-779-6798- Is this information wrong?
Education & Training
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2006
Boston University Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Massachusetts Medical SchoolClass of 1997
Certifications & Licensure
MA State Medical License 1999 - 2024- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- Clinical Manifestations of Subjects With the Non-Specific Pulmonary Function Test Pattern.James Tasch, Samer Abujaber, Laith Hattar, Aju Jose, Lori Lyn Price, Peter LaCamera, Hernan Avella> ;Open Respiratory Archives. 2023 Jun 15
- 1 citationsAnti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis.Todd L Astor, Hilary J Goldberg, Laurie D Snyder, Andrew Courtwright, Ramsey Hachem, Tahuanty Pena, Lorenzo Zaffiri, Gerard J Criner, Marie M Budev, Tany Thaniyavarn, ...> ;Therapeutic Advances in Respiratory Disease. 2023 Apr 19
- 3 citationsTRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial.Lorraine B Ware, Nima Soleymanlou, Danny Francis McAuley, Vicente Estrada, George A Diaz, Peter Lacamera, Renee Kaste, Wansuk Choi, Abhya Gupta, Tobias Welte> ;Thorax. 2023 Aug 1
- Join now to see all
Press Mentions
#ATS2018 – Start of Anti-Fibrotic Therapy in Newly Diagnosed IPF Patients Can Depend on Physician Preference, Survey FindsMay 31st, 2018
Hospital Affiliations
St. Elizabeth's Medical CenterBrighton, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
